Cargando…

The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation

Detalles Bibliográficos
Autores principales: Harrod, Robert, Romeo, Megan, Malu, Aditi, Hutchison, Tetiana, White, Averi, Gardner, Rachel, Nguyen, Olivia, Hazen, Catherine, Rao, Neha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577817/
http://dx.doi.org/10.1186/1742-4690-12-S1-P10
_version_ 1782391021984808960
author Harrod, Robert
Romeo, Megan
Malu, Aditi
Hutchison, Tetiana
White, Averi
Gardner, Rachel
Nguyen, Olivia
Hazen, Catherine
Rao, Neha
author_facet Harrod, Robert
Romeo, Megan
Malu, Aditi
Hutchison, Tetiana
White, Averi
Gardner, Rachel
Nguyen, Olivia
Hazen, Catherine
Rao, Neha
author_sort Harrod, Robert
collection PubMed
description
format Online
Article
Text
id pubmed-4577817
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45778172015-09-23 The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation Harrod, Robert Romeo, Megan Malu, Aditi Hutchison, Tetiana White, Averi Gardner, Rachel Nguyen, Olivia Hazen, Catherine Rao, Neha Retrovirology Poster Presentation BioMed Central 2015-08-28 /pmc/articles/PMC4577817/ http://dx.doi.org/10.1186/1742-4690-12-S1-P10 Text en Copyright © 2015 Harrod et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Harrod, Robert
Romeo, Megan
Malu, Aditi
Hutchison, Tetiana
White, Averi
Gardner, Rachel
Nguyen, Olivia
Hazen, Catherine
Rao, Neha
The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title_full The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title_fullStr The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title_full_unstemmed The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title_short The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
title_sort htlv-1 latency-maintenance factor p30ii activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577817/
http://dx.doi.org/10.1186/1742-4690-12-S1-P10
work_keys_str_mv AT harrodrobert thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT romeomegan thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT maluaditi thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT hutchisontetiana thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT whiteaveri thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT gardnerrachel thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT nguyenolivia thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT hazencatherine thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT raoneha thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT harrodrobert htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT romeomegan htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT maluaditi htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT hutchisontetiana htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT whiteaveri htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT gardnerrachel htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT nguyenolivia htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT hazencatherine htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation
AT raoneha htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation